Latest Conference Articles

Management of Age-Related Cognitive Decline

Management of Age-Related Cognitive Decline

December 7th 2019

Psych Congress

Patients with a family history of Alzheimer disease worry that normal aging symptoms are the initial indication of a progressive cognitive impairment that they have observed in their relatives. A variety of interventions are discussed.

Borderpolar: Patients with Borderline Personality Disorder and Bipolar Disorder

Borderpolar: Patients with Borderline Personality Disorder and Bipolar Disorder

December 4th 2019

Psych Congress

The most frequently researched aspect of the relationship between BPD and bipolar disorder has been the frequency of their co-occurrence. Several reviews have estimated a 20% overlap in diagnostic frequency.

Presenters at Psych Congress Share Clinical Tips, New Research

Presenters at Psych Congress Share Clinical Tips, New Research

November 27th 2019

Psych Congress

From addressing borderline personality disorder to preventing drug-drug interactions and more, Psych Congress faculty shared useful diagnostic and treatment information.

Innovative Non-Opioids for Chronic Pain: Ketamine and Cannabidiol

Innovative Non-Opioids for Chronic Pain: Ketamine and Cannabidiol

October 8th 2019

Psych Congress

This overview addresses two medications for analgesia of chronic benign pain, both of which have substance abuse risks themselves.

The Detective Work Needed to Understand the Causes of Agitation Seen in Dementia

The Detective Work Needed to Understand the Causes of Agitation Seen in Dementia

October 7th 2019

Psych Congress

Brain damage associated with dementia impairs affective regulation and executive function, and degrades cholinergic, serotonergic, and dopaminergic pathways. Dr Marc Agronin explains.

The Augmented Psychiatrist: How Technology Will Transform Mental Health Clinical Practice

The Augmented Psychiatrist: How Technology Will Transform Mental Health Clinical Practice

October 4th 2019

Psych Congress

Excitement in digital health is growing due to rapid advances in artificial intelligence, data science, and smart devices. How will the growing number of mental health technologies impact clinical practice? Arshya Vahabzadeh, MD provides insights.

Be Wary of P Values: Ask About Effect Size

Be Wary of P Values: Ask About Effect Size

October 4th 2019

Psych Congress

P values tell half of the story. A result that is statistically significant may actually be clinically irrelevant. More in this video.

OCD: A Common Psychiatric Disorder With a Constellation of Solutions

OCD: A Common Psychiatric Disorder With a Constellation of Solutions

October 4th 2019

Psych Congress

OCD is a serious psychiatric condition that can be effectively treated, with evidence-based approaches, in a majority of cases. There are, however, circumstances that complicate our treatment of OCD, and this article presents some of these issues.

Digital Psychiatry: Augmenting the Future of Mental Health Practice

Digital Psychiatry: Augmenting the Future of Mental Health Practice

October 4th 2019

Psych Congress

Technology will have an enormous impact on mental health, but perhaps not as soon as people think. Some of the earliest technologies to be deployed into clinical practice will help to augment clinicians, empower patients, and enable a data-driven approach to psychiatry.

Is This Clinical Trial Result Meaningful or Not? Effect Size Can Help Decide

Is This Clinical Trial Result Meaningful or Not? Effect Size Can Help Decide

October 3rd 2019

Psych Congress

P values can be deceiving. In order to determine if a clinical trial result is important, we need to look at the effect size.